Order Article Reprints

Alencastro Veiga Cruzeiro G, de Almeida Magalhães T, Ribeiro de Sousa G, Bonfim Silva R, Alberto Oliveira de Biagi Junior C, Ferreira das Chagas P, Gomes de Paula Queiroz R, Alberto Scrideli C, Gonzaga Tone L, Terci Valera E. YAP1 Is a Potential Predictive Molecular Biomarker for Response to SMO Inhibitor in Medulloblastoma Cells. Cancers. 2021; 13(24):6249. https://doi.org/10.3390/cancers13246249

Alencastro Veiga Cruzeiro, Gustavo, Taciani de Almeida Magalhães, Graziella Ribeiro de Sousa, Ricardo Bonfim Silva, Carlos Alberto Oliveira de Biagi Junior, Pablo Ferreira das Chagas, Rosane Gomes de Paula Queiroz, Carlos Alberto Scrideli, Luiz Gonzaga Tone, and Elvis Terci Valera. 2021. "YAP1 Is a Potential Predictive Molecular Biomarker for Response to SMO Inhibitor in Medulloblastoma Cells" Cancers 13, no. 24: 6249. https://doi.org/10.3390/cancers13246249

Alencastro Veiga Cruzeiro, G., de Almeida Magalhães, T., Ribeiro de Sousa, G., Bonfim Silva, R., Alberto Oliveira de Biagi Junior, C., Ferreira das Chagas, P., Gomes de Paula Queiroz, R., Alberto Scrideli, C., Gonzaga Tone, L., & Terci Valera, E. (2021). YAP1 Is a Potential Predictive Molecular Biomarker for Response to SMO Inhibitor in Medulloblastoma Cells. Cancers, 13(24), 6249. https://doi.org/10.3390/cancers13246249